Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cromoglicate lisetil

Drug Profile

Cromoglicate lisetil

Alternative Names: Cromoglicate lisetil hydrochloride; Cromoglicic acid; KY-556; LP-0074; N-556

Latest Information Update: 21 Jul 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kyoto Pharmaceutical Industries
  • Developer Asahi Kasei; Kyoto Pharmaceutical Industries; LEO Pharma
  • Class Antiallergics; Antiasthmatics; Antihistamines; Benzopyrans; Skin disorder therapies; Small molecules
  • Mechanism of Action Histamine release inhibitors; Mast cell stabilisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Mastocytosis; Psoriasis
  • Discontinued Allergic rhinitis; Asthma; Atopic dermatitis

Most Recent Events

  • 21 Jul 2015 No recent reports of development identified - Phase-II for Mastocytosis in Germany (Topical)
  • 21 Jul 2015 No recent reports of development identified - Phase-II for Psoriasis in Germany (Topical)
  • 01 May 2013 LEO Pharma completes a phase II trial in Psoriasis in Germany (NCT01722812)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top